Until now, no specific treatment is available for dementia or AD [16], but various therapeutic approaches such as amyloid-driven immunotherapy, inhibition of amyloid synthesis, and extracellular tau immunotherapy focus on alleviating symptoms [22,23,24]. The gene discussed is MAPT; the disease is dementia.